Medical recall notice: Emerade 0.3MG and 0.5MG
The recall notice is due to a potential risk that the auto-injector may fail to activate or it may activate prematurely if dropped.
Bausch Health, Canada Inc. issued a notice recalling all lots of Emerade epinephrine auto-injectors 0.3 mg (DIN 02458446) and 0.5 mg (DIN 02458454). The recall notice is due to a potential risk that the auto-injector may fail to activate or it may activate prematurely if dropped.
CBHSSJB clients who have an allergy for which he/she has an Emerade are requested to contact their clinic or pharmacy to have their Emerade replaced by Epipen as soon as possible.
If you or someone you know have an allergy for which he/she has an EMERADE, please:
- Return your Emerade auto-injector to your pharmacy for a replacement with Epipen as soon as possible
- Make sure you know how to use the Epipen;
- Do not return or dispose of your Emerade auto-injector until Epipen is obtained;
- If a life-threatening allergic reaction (anaphylaxis) happens before you can get a replacement, use your recalled Emerade and then seek emergency medical attention.
Come by the clinic/pharmacy to get your Emerade replaced by Epipen as soon as possible.
